Identifying the predictor of clinical efficacy and safety by genotype vs. phenotype in patients receiving clopidogrel underwent PCI

被引：0
|
作者：
Zhang Xiaoxing
Yuan Jinqing
Chen Jue
Gao Zhan
Qian Jie
Zhang Pei
Jia Youhong
Li Yishi
机构：
[1] CAMS, Fuwai Hosp, Minist Hlth, Key Lab Clin Trial Res Cardiovasc Drugs, Beijing, Peoples R China
[2] PUMC, Beijing, Peoples R China
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2014年 / 64卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
GW25-e1655
引用
收藏
页码：C119 / C120
页数：2
相关论文
共 50 条
  • [21] Efficacy and safety of briakinumab vs. methotrexate in patients with moderate to severe psoriasis
    Reich, K.
    Langley, R. G.
    Papp, K.
    Ortonne, J. -P.
    Unnebrink, K.
    Kaul, M.
    Valdes, J.
    BRITISH JOURNAL OF DERMATOLOGY, 2011, 165 : 4 - 4
  • [22] Erratum to: Comparison of Clinical Efficacy and Safety of Clopidogrel Resinate With Clopidogrel Bisulfate in Patients Undergoing Percutaneous Coronary Intervention
    Mahn-Won Park
    Seung Hee Jeong
    Sung Ho Her
    Pum-Joon Kim
    Jung Sun Cho
    Chan Joon Kim
    Wook-Sung Chung
    Ki-Bae Seung
    Hyeon-Woo Yim
    Kiyuk Chang
    Cardiovascular Drugs and Therapy, 2013, 27 : 483 - 483
  • [23] Comparative efficacy and safety of ticagrelor vs. prasugrel in patients undergoing PCI for NSTE-ACS. Results of the prospective ALKK-Registry
    Riedmaier, P.
    Hochadel, M.
    Ince, H.
    Darius, H.
    Hoffmeister, T.
    Zahn, R.
    Zeymer, U.
    EUROPEAN HEART JOURNAL, 2017, 38 : 1263 - 1263
  • [24] Comparative efficacy and safety of ticagrelor vs. prasugrel in patients undergoing PCI for NSTE-ACS. Results of the prospective ALKK-Registry
    Zeymer, U.
    Hochadel, M.
    Schaechinger, V.
    Zahn, R.
    EUROPEAN HEART JOURNAL, 2022, 43 : 1388 - 1388
  • [25] Superior safety of dual therapy with dabigatran and clopidogrel vs. triple therapy with warfarin, aspirin and clopidogrel in the RE-DUAL PCI trial: What is key, the strategy or the drug?
    Rubboli, Andrea
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2017, 46 : E40 - E41
  • [26] Clinical outcomes in patients with atrial fibrillation receiving amiodarone on NOACs vs. warfarin
    Ricardo Avendano
    Jorge Romero
    Florentino Lupercio
    Juan Carlos Diaz
    Renato Quispe
    Anjani Golive
    Andrea Natale
    Mario J. Garcia
    Andrew K. Krumerman
    Luigi Di Biase
    Journal of Interventional Cardiac Electrophysiology, 2019, 54 : 73 - 80
  • [27] Clinical outcomes in patients with atrial fibrillation receiving amiodarone on NOACs vs. warfarin
    Avendano, Ricardo
    Romero, Jorge
    Lupercio, Florentino
    Diaz, Juan Carlos
    Quispe, Renato
    Golive, Anjani
    Natale, Andrea
    Garcia, Mario J.
    Krumerman, Andrew K.
    Di Biase, Luigi
    JOURNAL OF INTERVENTIONAL CARDIAC ELECTROPHYSIOLOGY, 2019, 54 (01) : 73 - 80
  • [28] EFFECTS OF CANNABIDIOL VS. PLACEBO ON PHARMACODYNAMICS, PHARMACOGENETICS, AND CLINICAL EFFICACY AND SAFETY IN PATIENTS WITH FUNCTIONAL DYSPEPSIA: A RANDOMIZED TRIAL
    Atieh, Jessica
    Maselli, Daniel B.
    Breen-Lyles, Margaret K.
    Ryks, Michael
    Busciglio, Irene
    Burton, Duane D.
    Carlson, Paula
    Harmsen, William S.
    Camilleri, Michael
    GASTROENTEROLOGY, 2022, 162 (07) : S70 - S70
  • [29] Efficacy and safety of Levetiracetam vs. other antiepileptic drugs in Hispanic patients with glioblastoma
    Andrés F. Cardona
    Leonardo Rojas
    Beatriz Wills
    Laura Bernal
    Alejandro Ruiz-Patiño
    Oscar Arrieta
    Enrique Jiménez Hakim
    Fernando Hakim
    Juan Armando Mejía
    Nicolás Useche
    Sonia Bermúdez
    Hernán Carranza
    Carlos Vargas
    Jorge Otero
    Luis Carlos Mayor
    León Darío Ortíz
    Sandra Franco
    Carlos Ortíz
    Miguel Gil-Gil
    Carmen Balaña
    Zyanya Lucia Zatarain-Barrón
    Journal of Neuro-Oncology, 2018, 136 : 363 - 371
  • [30] Efficacy and safety of Levetiracetam vs. other antiepileptic drugs in Hispanic patients with glioblastoma
    Cardona, Andres F.
    Rojas, Leonardo
    Wills, Beatriz
    Bernal, Laura
    Ruiz-Patino, Alejandro
    Arrieta, Oscar
    Jimenez Hakim, Enrique
    Hakim, Fernando
    Armando Mejia, Juan
    Useche, Nicolas
    Bermudez, Sonia
    Carranza, Hernan
    Vargas, Carlos
    Otero, Jorge
    Carlos Mayor, Luis
    Dario Ortiz, Leon
    Franco, Sandra
    Ortiz, Carlos
    Gil-Gil, Miguel
    Balana, Carmen
    Lucia Zatarain-Barron, Zyanya
    JOURNAL OF NEURO-ONCOLOGY, 2018, 136 (02) : 363 - 371
12345